Rm. Rapoport et al., Phorbol ester-induced phosphoinositide hydrolysis in rat aorta - Role of cyclooxygenase products, LIFE SCI, 67(15), 2000, pp. 1815-1824
This study investigates whether phorbol esters increase phosphoinositide hy
drolysis in intact vascular smooth muscle, and the mechanism underlying the
hydrolysis. Phorbol myristate acetate induced time- and concentration-depe
ndent increases in phosphoinositide hydrolysis, as demonstrated by elevated
inositol monophosphate levels, in deendothelialized rat aorta. The phorbol
ester-elevated inositol monophosphate levels were abolished by indomethaci
n, a cyclooxygenase inhibitor, but were only partially decreased by SQ29548
, a thromboxane A(2)/prostaglandin H-2 receptor antagonist. SQ29548 also on
ly partially decreased elevated inositol monophosphate levels due to prosta
glandin E-2, prostaglandin F-2 alpha, prostaglandin I-2 and carbacyclin, a
stable prostaglandin I-2 analog. SQ29548 abolished elevated inositol monoph
osphate levels due to U46619, a stable thromboxane A(2)/prostaglandin H-2 r
eceptor agonist. These studies demonstrate that phorbol esters increase pho
sphoinositide hydrolysis in intact vascular smooth muscle, and that the inc
rease is due, at lease in part, to endogenously released prostaglandins oth
er than prostaglandin H-2. (C) 2000 Elsevier Science Inc. All rights reserv
ed.